Recent concepts of pharmacotherapy and bariatric surgery for childhood obesity: An overview

Pediatric Endocrinology Reviews

Volumn 7, Issue 2, 2009, Pages 3-14

  Gogakos, Apostolus ^a   Tzotzas, Themistoklis ^b   Krassas, Gerasimos E ^b  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b PANAGIA GENERAL HOSPITAL   (Greece)

Author keywords

Bariatric surgery; Childhood obesity; Metformin; Orlistat; Pharmacotherapy; Sibutramine

Indexed keywords

AMFEBUTAMONE; AMFEPRAMONE; EXENDIN 4; METFORMIN; OCTREOTIDE; PHENTERMINE; PLACEBO; RECOMBINANT LEPTIN; RIMONABANT; SIBUTRAMINE; TETRAHYDROLIPSTATIN; TOPIRAMATE; VITAMIN D; ZONISAMIDE;

ABDOMINAL DISCOMFORT; ANASTOMOSIS LEAKAGE; BARIATRIC SURGERY; CHILDHOOD DISEASE; CHILDHOOD OBESITY; CHOLECYSTECTOMY; CHOLECYSTITIS; CHOLELITHIASIS; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; CONSTIPATION; DEFECATION; DEHYDRATION; DEPRESSION; DIARRHEA; DIASTOLIC BLOOD PRESSURE; DIET THERAPY; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG SAFETY; DRUG WITHDRAWAL; FLATULENCE; FOLLOW UP; GALLBLADDER DISEASE; GASTRECTOMY; GASTRIC BANDING; GASTROINTESTINAL SYMPTOM; HEART RATE; HERNIA; HOSPITALIZED CHILD; HUMAN; INSOMNIA; INTESTINE OBSTRUCTION; KINESIOTHERAPY; LACTIC ACIDOSIS; LAPAROSCOPIC VERTICAL SLEEVE GASTRECTOMY; LIFESTYLE MODIFICATION; LONG TERM CARE; MALABSORPTION; MORBID OBESITY; NAUSEA; OSTEOPENIA; PATIENT COUNSELING; PATIENT SAFETY; REVIEW; ROUX Y ANASTOMOSIS; SIDE EFFECT; SUICIDAL BEHAVIOR; SYSTOLIC HYPERTENSION; ULCER; VITAMIN DEFICIENCY; VITAMIN SUPPLEMENTATION; WEIGHT REDUCTION; XEROSTOMIA;

ADOLESCENT; ANTI-OBESITY AGENTS; BARIATRIC SURGERY; CHILD; HUMANS; OBESITY; OBESITY, MORBID; PEDIATRICS; POSTOPERATIVE COMPLICATIONS; WEIGHT LOSS;

EID: 78649991100     PISSN: 15654753     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (83)

1. James WP. WHO recognition of the global obesity epidemic. Int J Obes (Lond) 2008;32(Suppl 7):S120-S126
2. Ogden CL, Yanovski SZ, Carroll MD, Flegal KM. The epidemiology of obesity. Gastroenterology 2007;132:2087-2102
3. Ogden CL, Carroll MD, Flegal KM. High body mass index for age among US children and adolescents, 2003-2006. JAMA 2008;299:2401-2405
4. Lobstein T, Jackson-Leach R. Child overweight and obesity in the USA: prevalence rates according to IOTF definitions. Int J Pediatr Obes 2007;2:62-64 (Pubitemid 46745352)
5. Janssen I, Katzmarzyk PT, Boyce WF, Vereecken C, Mulvihill C, Roberts C, Currie C, Pickett W; Health Behaviour in School-Aged Children Obesity Working Group. Comparison of overweight and obesity prevalence in school-aged youth from 34 countries and their relationships with physical activity and dietary patterns. Obes Rev 2005;6:123-132
6. Tzotzas T, Krassas GE. Prevalence and trends of obesity in children and adults of South Europe. Pediatr Endocrinol Rev 2004;1(Suppl 3):448-454
7. Jackson-Leach R, Lobstein T. Estimated burden of pediatric obesity and co-morbidities in Europe. Part 1. The increase in the prevalence of child obesity in Europe is itself increasing. Int J Ped Obes 2006;1:26-32
8. Wang G, Dietz WH. Economic burden of obesity in youths aged 6 to 17 years:1979-1999. Pediatrics 2002;109:E81-E181
9. Artz E, Haqq A, Freemark M. Hormonal and metabolic consequences of childhood obesity. Endocrinol Metab Clin North Am 2005;34:643-658
10. Weiss R, Dziura J, Burgert TS, Tamborlane WV, Taksali SE, Yeckel CW, Allen K, Lopes M, Savoye M, Morrison J, Sherwin RS, Caprio S. Obesity and the metabolic syndrome in children and adolescents. N Engl J Med 2004;350:2362-2374 (Pubitemid 38702847)
11. Goran MI, Ball GD, Cruz ML. Obesity and risk of type 2 diabetes and cardiovascular disease in children and adolescents. J Clin Endocrinol Metab 2003;88:1417-1427
12. Krassas GE, Tzotzas T. Do obese children become obese adults: childhood predictors of adult disease. Pediatr Endocrinol Rev 2004;1(Suppl 3):455-459
13. Speiser PW, Rudolf MC, Anhalt H, Camacho-Hubner C, Chiarelli F, Eliakim A, Freemark M, Gruters A, Hershkovitz E, Iughetti L, Krude H, Latzer Y, Lustig RH, Pescovitz OH, Pinhas-Hamiel O, Rogol AD, Shalitin S, Sultan C, Stein D, Vardi P, Werther GA, Zadik Z, Zuckerman-Levin N, Hochberg Z; Obesity Consensus Working Group. Childhood obesity. J Clin Endocrinol Metab 2005;90:1871-1887
14. Uli N, Sundararajan S, Cuttler L. Treatment of childhood obesity. Curr Opin Endocrinol Diabetes Obes 2008;15:37-47
15. Lee WW. An overview of pediatric obesity. Pediatr Diabetes 2007;8(Suppl 9):76-87
16. Fowler-Brown A, Kahwati LC. Prevention and treatment of overweight in children and adolescents. Am Fam Physician 2004;69:2591-2598 (Pubitemid 38724146)
17. Guerciolini R. Mode of action of orlistat. Int J Obes Relat Metab Disord 1997;21(Suppl 3):S12-S23
18. Zhi J, Melia AT, Eggers H, Joly R, Patel IH. Review of limited systemic absorption of orlistat, a lipase ihibitor, in healthy human volunteers. J Clin Pharmacol 1995;35:1103-1108
19. Filippatos TD, Derdemezis CS, Gazi IF, Nakou ES, Mikhailidis DP, Elisaf MS. Orlistat-associated adverse effects and drug interactions: a critical review. Drug Saf 2008;31:53-65
20. Dunican KC, Desilets AR, Montalbano JK. Pharmacotherapeutic Options for Overweight Adolescents. Ann Pharmacother 2007;41:1445-1455
21. McDuffie JR, Calis KA, Uwaifo GI, Sebring NG, Fallon EM, Hubbard VS, Yanovski JA. Three-month tolerability of orlistat in adolescents with obesity-related comorbid conditions. Obes Res 2002;10:642-650
22. McDuffie JR, Calis KA, Uwaifo GI, Sebring NG, Fallon EM, Frazer TE, Van Hubbard S, Yanovski JA. Efficacy of orlistat as an adjunct to behavioral treatment in overweight African American and Caucasian adolescents with obesity-related co-morbid conditions. J Pediatr Endocrinol Metab 2004;17:307-319
23. Chanoine JP, Hampl S, Jensen C, Boldrin M, Hauptman J. Effect of orlistat on weight and body composition in obese adolescents: a randomized controlled trial. JAMA 2005;293:2873-2883
24. Norgren S, Danielsson P, Jurold R, Lotborn M, Marcus C. Orlistat treatment in obese prepubertal children: a pilot study. Acta Paediatr 2003;92:666-670
25. Ozkan B, Bereket A, Turan S, Keskin S. Addition of orlistat to conventional treatment in adolescents with severe obesity. Eur J Pediatr 2004;163:738-741
26. Maahs D, de Serna DG, Kolotkin RL, Ralston S, Sandate J, Qualls C, Schade DS. Randomized, double-blind, placebo-controlled trial of orlistat for weight loss in adolescents. Endocr Pract 2006;12:18-28
27. Leung WYS, Thomas N, Chan JCN, Tomilnson B. Weight management and current options in pharmacotherapy: orlistat and sibutramine. Clin Ther 2003;25:58-80
28. McDuffie JR, Calis KA, Booth SL, Uwaifo GI, Yanovski JA. Effects of orlistat on fat-soluble vitamins in obese adolescents. Pharmacotherapy 2002;22:814-822
29. Bray GA, Greenway FL. Pharmacological treatment of the overweight patient. Pharmacol Rev 2007;59:151-184
30. Halford JC. Pharmacotherapy for obesity. Appetite 2006;46:6-10
31. Tziomalos K, Krassas GE, Tzotzas T. The use of sibutramine in the management of obesity and related disorders: an update. Vasc Health Risk Manag 2009:5;441-452
32. Berkowitz RI, Wadden TA, Tershakovec AM, Cronquist JL. Behavior therapy and sibutramine for the treatment of adolescent obesity: a randomized controlled trial. JAMA 2003;289:1805-1812 (Pubitemid 37430250)
33. Berkowitz RI, Fujioka K, Daniels SR, Hoppin AG, Owen S, Perry AC, Sothern MS, Renz CL, Pirner MA, Walch JK, Jasinsky O, Hewkin AC, Blakesley VA; Sibutramine Adolescent Study Group. Effects of sibutramine treatment in obese adolescents: a randomized trial. Ann Intern Med 2006;145:81-90
34. Godoy-Matos A, Carraro L, Vieira A, Oliveira J, Guedes EP, Mattos L, Rangel C, Moreira RO, Coutinho W, Appolinario JC. Treatment of obese adolescents with sibutramine: a randomized, double-blind, controlled study. J Clin Endocrinol Metab 2005;90:1460-1465 (Pubitemid 40464005)
35. Garcia-Morales LM, Berber A, Macias-Lara CC, Lucio-Ortiz C, Del-Rio-Navarro BE, Dorantes-Alvarez LM. Use of sibutramine in obese Mexican adolescents: a 6-month, randomized, double-blind, placebo-controlled,parallel- group trial. Clin Ther 2006;28:770-782
36. Violante-Ortìz R, Del-Rio-Navarro BE, Lara-Esqueda A, Pèrez P, Fanghänel G, Madero A, Berber A. Use of sibutramine in obese Hispanic adolescents. Adv Ther 2005;22:642-649 (Pubitemid 44409559)
37. Van Mil, Westerterp KR, Kester AD, Delemarre-van de Waal HA, Gerver WJ, Saris WH. The effect of sibutramine on energy expenditure and body composition in obese adolescents. J Clin Endocrinol Metab 2007;92:1409-1414 (Pubitemid 46556418)
38. Pinkney J, Wilding J, Williams G, MacFarlane I. Hypothalamic obesity in humans: what do we know and what can be done? Obes Rev 2002;3:27-34
39. Tzotzas T, Papazisis K, Perros P, Krassas GE. Use of somatostatin analogues in obesity. Drugs 2008;68:1963-1973
40. Danielsson P, Janson A, Norgren S, Marcus C. Impact sibutramine therapy in children with hypothalamic obesity or obesity with aggravating syndromes. J Clin Endocrinol Metab 2007;92:4101-4106
41. McGovern L, Johnson JN, Paulo R, Hettinger A, Singhal V, Kamath C, Erwin PJ, Montori VM. Treatment of pediatric obesity. A systematic review and meta-analysis of randomized trials. J Clin Endocrinol Metab 2008;93:4600-4605
42. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, Nathan DM; Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002;346:393-403
43. Zhou G, Myers R, Li Y, Chen Y, Shen X, Fenyk-Melody J, Wu M, Ventre J, Doebber T, Fujii N, Musi N, Hirshman MF, Goodyear LJ, Moller DE. Role of AMPactivated protein kinase in mechanism of metformin action. J Clin Invest 2001;108:1167-1174
44. Freemark M, Bursey D. The effects of metformin on body mass index and glucose tolerance in obese adolescents with fasting hyperinsulinemia and a family history of type 2 diabetes. Pediatrics 2001;107:E55
45. Kay JP, Alemzadeh R, Langley G, D'Angelo L, Smith P, Holshouser S. Beneficial effects of metformin in normoglycemic morbidly obese adolescents. Metabolism 2001;50:1457-1461
46. Srinivasan S, Ambler GR, Baur LA, Garnett SP, Tepsa M, Yap F, Ward GM, Cowell CT. Randomized, controlled trial of metformin for obesity and insulin resistance in children and adotescents: improvement in body composition and fasting insulin. J Clin Endocrinol Metab 2006;91:2074-2080
47. Fu JF, Liang L, Zou CC, Hong F, Wang CL, Wang XM, Zhao ZY. Prevalence of the metabolic syndrome in Zhejiang Chinese obese children and adolescents and the effect of metformin combined with lifestyle intervention. Int J Obes 2007;31:15-22 (Pubitemid 46006010)
48. Jones D. End of the line for cannabinoid receptor 1 as an anti-obesity target? Nat Rev Drug Discov 2008;7:961-962
49. Lustig RH, Rose SR, Burghen GA, Velasquez-Mieyer P, Broome DC, Smith K, Li H, Hudson MM, Heideman RL, Kun LE. Hypothalamic obesity caused by cranial insult in children: altered glucose and insulin dynamics and reversal by a somatostatin agonist. J Pediatr 1999;135(2 Pt 1):162-168 (Pubitemid 30180530)
50. Lustig RH, Hinds PS, Ringwald-Smith K, Christensen RK, Kaste SC, Schreiber RE, Rai SN, Lensing SY, Wu S, Xiong X. Octreotide therapy of pediatric hypothalamic obesity: a double-blind, placebo-controlled trial. J Clin Endocrinot Metab 2003;88:2586-2592 (Pubitemid 36724428)
51. Blüher S, Mantzoros CS. Leptin in humans: lessons from translational research. Am J Clin Nutr 2009;89:S991-S997
52. Barlow SE. Expert committee recommendations regarding the prevention, assessment, and treatment of child and adolescent overweight and obesity: summary report. Pediatrics 2007;120(Suppl 4):S164-S192
53. Freemark M. Pharmacotherapy of childhood obesity: an evidence-based, conceptual approach. Diabetes Care 2007;30:395-402 (Pubitemid 46198355)
54. Buchwald H, Avidor Y, Braunwald E, Jensen MD, Pories W, Fahrbach K, Schoelles K. Bariatric surgery: a systematic review and meta-analysis. JAMA 2004;292:1724-1737
55. Maggard MA, Shugarman LR, Suttorp M, Maglione M, Sugerman HJ, Livingston EH, Nguyen NT, Li Z, Mojica WA, Hilton L, Rhodes S, Morton SC, Shekelle PG. Meta-analysis: surgical treatment of obesity. Ann Intern Med 2005;142:547-559
56. Xanthakos SA. Bariatric surgery for extreme adolescent obesity: Indications,outcomes, and physiologic effects on the gut-brain axis. Pathophysiology 2008;15:135-146
57. Inge T, Helmrath M, Vierra M, Ikramuddin S. Challenges of adolescent bariatric surgery: tips for managing the extremely obese teen. J Laparoendosc Adv Surg Tech A 2008;18:157-169
58. Inge TH, Krebs NF, Garcia VF, Skelton JA, Guice KS, Strauss RS, Albanese CT, Brandt ML, Hammer LD, Harmon CM, Kane TD, Klish WJ, Oldham KT, Rudolph CD, Helmrath MA, Donovan E, Daniels SR. Bariatric surgery for severely overweight adolescents: concerns and recommendations. Pediatrics 2004;114:217-223
59. Pratt JS, Lenders CM, Dionne EA, Hoppin AG, Hsu GL, Inge TH, Lawlor DF, Marino MF, Meyers AF, Rosenblum JL, Sanchez VM. Best practice updates for pediatric/adolescent weight loss surgery. Obesity (Silver Spring) 2009;17:901-910
60. Lynn CH, Miller JL. Bariatric surgery for obese adolescents: should surgery be used to treat the childhood obesity epidemic? Pediatr Health 2009;3:33-40
61. Gracia JA, Martínez M, Elia M, Aguilella V, Royo P, Jiménez A, Bielsa MA, Arribas D. Obesity surgery results depending on technique performed: long-term outcome. Obes Surg 2009;19:432-438
62. Lawson ML, Kirk S, Mitchell T, Chen MK, Jean Loux T, Daniels SR, Harmon CM, Clements RH, Garcia VF, Inge TH. One-year outcomes of Roux-en-Y gastric bypass for morbidly obese adolescents: a multicenter study from the Pediatric Bariatric Study Group. J Pediatr Surg 2006;41:137-143
63. Strauss RS, Bradley LJ, Brolin RE. Gastric bypass surgery in adotscents with morbid obesity. J Pediatr 2001;138:499-504
64. Sugerman HJ, Sugerman EL, DeMaria EJ, Kellum JM, Kennedy C, Mowery Y, Wolfe LG. Bariatric surgery for severely obese adolescents. J Gastrointest Surg 2003;7:102-108
65. Biagini J, Karam L. Ten years experience with laparoscopic adjustable gastric banding. Obes Surg 2008;18:573-577
66. Fielding GA, Duncombe JE. Laparoscopic adjustable gastric banding in severely obese adolescents. Surg Obes Relat Dis 2005;1:399-405
67. Dolan K, Fielding G. A comparison of laparoscopic adjustable gastric banding in adolescents and adults. Surg Endosc 2004;18:45-47 (Pubitemid 38133841)
68. Dillard BE 3rd, Gorodner V, Galvani C, Holterman M, Browne A, Gallo A, Horgan S, Le Holterman AX. Initial experience with the adjustable gastric band in morbidly obese US adolescents and recommendations for further investigation. J Pediatr Gastroenterol. Nutr 2007;45:240-246
69. Iannelli A, Dainese R, Piche T, Facchiano E, Gugenheim J. Laparoscopic sleeve gastrectomy for morbid obesity. World J Gastroenterol 2008;14:821-827
70. Roa PE, Kaidar-Person O, Pinto D, Cho M, Szomstein S, Rosenthal RJ. Laparoscopic sleeve gastrectomy as treatment for morbid obesity: technique and short-term outcome. Obes Surg 2006;16:1323-1326
71. Uglioni B, Wölnerhanssen B, Peters T, Christoffel-Courtin C, Kern B, Peterli R. Midterm results of primary vs. secondary laparoscopic sleeve gastrectomy (lsg) as an isolated operation. Obes Surg 2009;19:401-406
72. Till H, Blüher S, Hirsch W, Kiess W. Efficacy of laparoscopic sleeve gastrectomy (LSG) as a stand-alone technique for children with morbid obesity. Obes Surg 2008;18:1047-1049
73. Till HK, Muensterer O, Keller A, Körner A, Blueher S, Merkle R, Kiess W. Laparoscopic sleeve gastrectomy achieves substantial weight loss in an adolescent girl with morbid obesity. Eur J Pediatr Surg 2008;18:47-49
74. Treadwell JR, Sun F, Schoelles K. Systematic review and meta-analysis of bariatric surgery for pediatric obesity. Ann surg 2008;248:763-776
75. Woods SC, D'Alessio DA. Central Control of Body Weight and Appetite. J Clin Endocrinol Metab 2008;93:S37-S50
76. Frühbeck G, Diez Caballero A, Gil MJ. Fundus functionality and ghrelin concentrations after bariatric surgery. N Engl J Med 2004;350:308-309
77. le Roux CW, Aylwin SJ, Batterham RL, Borg CM, Coyle F, Prasad V, Shurey S, Ghatei MA, Patel AG, Bloom SR. Gut hormone profiles following bariatric surgery favor an anorectic state, facilitate weight loss, and improve metabolic parameters. Ann Surg 2006;243:108-114
78. Inge TH, Miyano G, Bean J, Helmrath M, Courcoulas A, Harmon CM, Chen MK, Wilson K, Daniels SR, Garcia VF, Brandt ML, Dolan LM. Reversal of type 2 diabetes mellitus and improvements in cardiovascular risk factors after surgical weight loss in adolescents. Pediatrics 2009;123:214-222
79. Levitsky LL, Misra M, Boepple PA, Hoppin AG. Adolescent obesity and bariatric surgery. Curr Opin Endocrinol Diabetes Obes 2009;16:37-44
80. Inge TH, Xanthakos SA, Zeller MH. Bariatric surgery for pediatric extreme obesity: now or later? Int J Obes (Lond) 2007;31:1-14
81. Zeller MH, Modi AC, Noll JG, Long JD, Inge TH. Psychosocial functioning improves following adolescent bariatric surgery. Obesity (Silver Spring) 2009;17:985-990
82. Iqbal CW, Kumar S, Iqbal AD, Ishitani MB. Perspectives on pediatric bariatric surgery: identifying barriers to referral. Surg Obes Relat Dis 2009;5:88-93
83. Apovian CM, Baker C, Ludwig DS, Hoppin AG, Hsu G, Lenders C, Pratt JS, Forse RA, O'brien A, Tarnoff M. Best practice guidelines in pediatric/adolescent weight loss surgery. Obes Res 2005;13:274-282